Key result
Intracoronary injection of bone marrow-derived stem cells significantly decreased scarred segments and infarct size, and increased myocardial blood flow (P<0.05) after recent AMI.
Why the study?
Does intracoronary stem cell injection improve myocardial perfusion and metabolism assessed by PET in patients with recent AMI?
RCT (n=15)
randomly assigned
Does intracoronary stem cell injection improve myocardial perfusion and metabolism assessed by PET in patients with recent AMI?
13N-ammonia and 18F-FDG PET imaging can effectively track improvements in myocardial perfusion and infarct size following bone marrow-derived stem cell therapy in patients with recent AMI.
Supports intracoronary stem cell therapy after recent AMI; extends PET validation for tracking perfusion and viability changes.
UNLABELLED: Over the last decade, the effects of stem cell therapy on cardiac repair after acute myocardial infarction (AMI) have been investigated with different imaging techniques. We evaluated a new imaging approach using (13)N-ammonia and (18)F-FDG PET for a combined analysis of cardiac perfusion, metabolism, and function in patients treated with intracoronary injection of endothelial progenitors or with conventional therapy for AMI. METHODS: A total of 15 patients were randomly assigned to 3 groups based on different treatments (group A: bone marrow-derived stem cells; group B: peripheral blood-derived stem cells; group C: standard therapy alone). The number of scarred and viable segments, along with the infarct size and the extent of the viable area, were determined on a 9-segment (13)N-ammonia/(18)F-FDG PET polar map. Myocardial blood flow (MBF) was calculated for each segment on the ammonia polar map, whereas a global evaluation of left ventricular function was obtained by estimating left ventricular ejection fraction (LVEF) and end-diastolic volume, both derived from electrocardiography-gated (18)F-FDG images. Both intragroup and intergroup comparative analyses of the mean values of each parameter were performed at baseline and 3, 6, and 12 mo after AMI. During follow-up, major cardiac events were also registered. RESULTS: A significant decrease (P < 0.05) in the number of scarred segments and infarct size was observed in group A, along with an increase in MBF (P < 0.05) and a mild improvement in cardiac function. Lack of infarct size shrinkage in group B was associated with a marked impairment of MBF (P = 0.01) and cardiac dysfunction. Ambiguous changes in infarct size, MBF, and LVEF were found in group C. No differences in number of viable segments or in extent of viable area were found among the groups. At clinical follow-up, no major cardiac events occurred in group A patients, whereas 2 patients of group B experienced in-stent occlusion and one patient of group C received a transplant for heart failure. CONCLUSION: Our data suggest that a single nuclear imaging technique accurately analyzes changes in myocardial perfusion and metabolism occurring after stem cell transplantation.
No takes yet. Share an insight, caveat, or question.
Castellani et al. (2010) conducted an RCT in Acute myocardial infarction (n=15). Intracoronary injection of bone marrow-derived or peripheral blood-derived stem cells vs. Standard therapy alone was evaluated on Changes in cardiac perfusion, metabolism, and function (scarred segments, infarct size, MBF, LVEF) (p=<0.05). Intracoronary injection of bone marrow-derived stem cells significantly decreased scarred segments and infarct size, and increased myocardial blood flow (P<0.05) after recent AMI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: